Bioequivalence studies of a new valproic acid delayed-release capsule and divalproex sodium delayed-release tablet

Author： Garikipati Vandana Toops Dana S. Fang Qi

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.24, Iss.7, 2008-07, pp. : 1869-1876

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review of the New Delayed‐Release Oral Tablet and Intravenous Dosage Forms of Posaconazole

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 2, 2015-02 ,pp. : 208-219

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of posaconazole delayed‐release tablets for treatment of invasive aspergillosis

MYCOSES (ELECTRONIC), Vol. 58, Iss. 5, 2015-05 ,pp. : 313-314

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost analysis of divalproex sodium extended-release compared to valproic acid in the treatment of bipolar disorder

By Schumock Glen T. Walton Surrey M. Gupta Shiraz R. Cramer Joyce A.

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1997-2004

Informa Healthcare

Access to resources Recommend Favorite

Release of Revised 2010 National Patient Safety Goals Delayed

JCAH Perspectives, Vol. 29, Iss. 6, 2009-06 ,pp. : 5-5

Joint Commission Resources

Access to resources Recommend Favorite

Delayed release of brain natriuretic peptide to identify myocardial ischaemia

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 11, 2015-11 ,pp. : 1175-1183

John Wiley & Sons Inc

Access to resources Recommend Favorite